申请人:SPHINGOTEC THERAPEUTICS GMBH
公开号:US20190145981A1
公开(公告)日:2019-05-16
The present invention is directed to methods for determining active DPP3 in a bodily fluid sample, an assay or kit for determining active DPP3 in a bodily fluid sample, a method for diagnosing a disease or condition in a subject accompanied by or related to necrotic processes and methods of treating or preventing said disease.